Your browser doesn't support javascript.
loading
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.
Mariño, Eliana; Richards, James L; McLeod, Keiran H; Stanley, Dragana; Yap, Yu Anne; Knight, Jacinta; McKenzie, Craig; Kranich, Jan; Oliveira, Ana Carolina; Rossello, Fernando J; Krishnamurthy, Balasubramanian; Nefzger, Christian M; Macia, Laurence; Thorburn, Alison; Baxter, Alan G; Morahan, Grant; Wong, Lee H; Polo, Jose M; Moore, Robert J; Lockett, Trevor J; Clarke, Julie M; Topping, David L; Harrison, Leonard C; Mackay, Charles R.
Affiliation
  • Mariño E; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Richards JL; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • McLeod KH; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Stanley D; Central Queensland University, School of Medical and Applied Sciences, Rockhampton, Australia.
  • Yap YA; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Knight J; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • McKenzie C; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Kranich J; Institute for Immunology, Ludwig Maximilians University, Munich, Munich, Germany.
  • Oliveira AC; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Rossello FJ; Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.
  • Krishnamurthy B; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Clayton, Australia.
  • Nefzger CM; Australian Regenerative Medicine Institute, Monash University, Clayton, Australia.
  • Macia L; Islet Biology Laboratory, St Vincent's Institute, Fitzroy, Australia.
  • Thorburn A; Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.
  • Baxter AG; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Clayton, Australia.
  • Morahan G; Australian Regenerative Medicine Institute, Monash University, Clayton, Australia.
  • Wong LH; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Polo JM; Nutritional Immunometabolism Node Laboratory, Charles Perkins Centre, University of Sydney, Sydney, Australia.
  • Moore RJ; School of Medical Sciences, University of Sydney, Sydney, Australia.
  • Lockett TJ; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Clarke JM; Comparative Genomics Centre, Molecular Sciences, James Cook University, Townsville, Australia.
  • Topping DL; Harry Perkins Institute for Medical Research, Nedlands, Australia.
  • Harrison LC; Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.
  • Mackay CR; Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.
Nat Immunol ; 18(5): 552-562, 2017 05.
Article in En | MEDLINE | ID: mdl-28346408
ABSTRACT
Gut dysbiosis might underlie the pathogenesis of type 1 diabetes. In mice of the non-obese diabetic (NOD) strain, we found that key features of disease correlated inversely with blood and fecal concentrations of the microbial metabolites acetate and butyrate. We therefore fed NOD mice specialized diets designed to release large amounts of acetate or butyrate after bacterial fermentation in the colon. Each diet provided a high degree of protection from diabetes, even when administered after breakdown of immunotolerance. Feeding mice a combined acetate- and butyrate-yielding diet provided complete protection, which suggested that acetate and butyrate might operate through distinct mechanisms. Acetate markedly decreased the frequency of autoreactive T cells in lymphoid tissues, through effects on B cells and their ability to expand populations of autoreactive T cells. A diet containing butyrate boosted the number and function of regulatory T cells, whereas acetate- and butyrate-yielding diets enhanced gut integrity and decreased serum concentration of diabetogenic cytokines such as IL-21. Medicinal foods or metabolites might represent an effective and natural approach for countering the numerous immunological defects that contribute to T cell-dependent autoimmune diseases.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Butyrates / B-Lymphocytes / T-Lymphocytes, Regulatory / Colon / Diabetes Mellitus, Type 1 / Dysbiosis / Acetates Limits: Animals Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Butyrates / B-Lymphocytes / T-Lymphocytes, Regulatory / Colon / Diabetes Mellitus, Type 1 / Dysbiosis / Acetates Limits: Animals Language: En Year: 2017 Type: Article